WEHEALTH BY SERVIER
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

WEHEALTH BY SERVIER Trademark

Serial Number: 79214952 • Registration: 5808887

WEHEALTH BY SERVIER is a trademark filed by LES LABORATOIRES SERVIER, Société par actions simplifiée on November 10, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently registered and active.

Trademark Details

Filing Date

November 10, 2016

Registration Date

July 23, 2019

Published for Opposition

May 7, 2019

Cancellation Date

February 6, 2026

Goods & Services

Pharmaceutical preparations, medical and veterinary preparations for the prevention and the treatment of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; sanitary products for medical purposes, namely, sanitary towels, sanitary napkins, sanitary sterilizing preparations; dietetic food adapted for medical or veterinary use; food for babies; dietary food supplements for humans and animals; plasters for medical purposes, namely material for dressings; materials for dental fillings and dental impressions; disinfectants; preparations for destroying vermin; fungicides; herbicides

Medical apparatus and instruments for the treatment and prevention of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; medical apparatus and instruments for monitoring, diagnosis, surveillance and alerts relating to heart, neurological, oncological, metabolic, respiratory and physiological disorders, namely oximeters, ECG (electrocardiographs), apparatus for monitoring eye movements, body position sensors, accelerometer and also including electro-conductive clothing sold as a unit and connected bracelets sold as a unit; Artificial limbs, eyes and artificial teeth; suture materials; Medical devices, for the treatment, surveillance and prevention of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; Diagnostic and monitoring devices for medical purposes in the fields of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; Medical devices, for the treatment, surveillance and prevention of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; Diagnostic and monitoring devices for medical purposes of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders

Scientific apparatus and instruments for use in the fields of cardiovascular, immune-inflammatory, respiratory, neurodegenerative, oncological, metabolic and osteoporosis diseases and disorders, namely, optical mirrors, spectrometers and chromatography columns; Optical apparatus and instruments, namely, optical transmitters; Weighing apparatus and instruments, namely, weighing machines, weighing scales; Measuring apparatus and instruments in the nature of wearable activity trackers; Signal splitters for electronic apparatus; Teaching apparatus and instruments in the fields of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; Apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity, namely, electric current transformers, electric power distribution units; Electronic apparatus for recording, transmission or reproduction of sound or images; Blank magnetic disks; blank optical disks for sound recording; apparatus and instruments for the processing of data information, namely, central processing units; Downloadable computer software for processing information from medical monitoring devices for monitoring physical and physiological signals, for the analysis, storage and monitoring of physiological data, including diagnostic, surveillance and warning tools; Computer programs for use in connection with managing electronic data and databases, database administration, managing cloud applications, and self-automation of database-management activities ; Data processing equipment, namely, couplers; Downloadable computer software applications for diagnosis, surveillance, prevention and treatment in the fields of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; Downloadable computer software for the analysis, storage and monitoring of physiological data, in the nature of diagnostic, surveillance and warning tools; personal digital assistants; transmitters of electronic signals, for the prevention and treatment in the fields of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; Wearable computers, namely, wearable activity trackers in the nature of wirelessly connected bracelets for treating, monitoring and medically analyzing physical and physiological signals; video cameras; Wearable computers, namely, wearable activity trackers in the nature of bracelets that track physical and physiological activity and signals; application software in the field of digital health for monitoring physical and physiological signals in the field of digital health

Medical services; Medical services provided via the internet, namely, online medical prescription services; Medical services, namely, medical consultation for patients with cardiovascular, immune-inflammatory, respiratory, neurodegenerative, oncological, metabolic and osteoporosis diseases and disorders provided via electronic and telematic means; Medical services, namely, medical surveillance and assistance for patients with cardiovascular, immune-inflammatory, respiratory, neurodegenerative, oncological, metabolic and osteoporosis diseases and disorders provided via electronic and telematic means; health counseling services; providing information in the field of pharmaceutical services; healthcare services, namely physical therapy, athletic training for prevention of injury and therapeutic purposes, occupational therapy, nutritional counseling therapy, hormone replacement therapy, geriatric healthcare services, cardiac rehabilitation therapy, home care personalized services, counseling regarding self-medication, counseling regarding home medical treatment, individualized medical prescription services, provision of support in the follow-up of patients receiving medical treatment, remote medical monitoring of patients; telemedicine services, namely, physical therapy, athletic training for prevention of injury and therapeutic purposes, occupational therapy, nutritional counseling therapy, hormone replacement therapy, geriatric healthcare services, cardiac rehabilitation therapy, home care personalized services, counseling regarding self-medication, counseling regarding home medical treatment, individualized medical prescription services, provision of support in the follow-up of patients receiving medical treatment, remote medical monitoring of patients, all of the aforesaid services provided remotely ; therapeutic services, namely, physical therapy, athletic training for prevention of injury and therapeutic purposes, occupational therapy, nutritional counseling therapy, hormone replacement therapy, geriatric healthcare services, cardiac rehabilitation therapy, home care personalized services, counseling regarding self-medication, counseling regarding home medical treatment, individualized medical prescription services, provision of support in the follow-up of patients receiving medical treatment, remote medical monitoring of patients; medical diagnosis of cardiovascular, immune-inflammatory, respiratory, neurodegenerative, oncological, metabolic and osteoporosis diseases and disorders; medical diagnostic services of cardiovascular, immune-inflammatory, respiratory, neurodegenerative, oncological, metabolic and osteoporosis diseases and disorders provided via electronic and telematic means

Filing History

CANCELLED SECTION 71
Feb 6, 2026 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 23, 2024 REM3
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 27, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 27, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 27, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 27, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 27, 2024 COAR
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 10, 2020 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Nov 12, 2019 XXSS
GENERIC MADRID TRANSACTION CREATED
Nov 12, 2019 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 23, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 23, 2019 R.PR
NOTIFICATION PROCESSED BY IB
May 31, 2019 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 7, 2019 NPUB
PUBLISHED FOR OPPOSITION
May 7, 2019 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 17, 2019 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 17, 2019 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 17, 2019 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 14, 2019 CNSA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Feb 15, 2019 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 30, 2019 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 30, 2019 OPNR
EXAMINER'S AMENDMENT ENTERED
Dec 18, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 18, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 18, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 18, 2018 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Oct 19, 2018 ZZZX
WITHDRAWN FROM PUB - MANAGING ATTORNEY REQUEST
Oct 19, 2018 PBMR
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 24, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 18, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 17, 2018 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sep 17, 2018 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
May 22, 2018 GNFN
FINAL REFUSAL E-MAILED
May 22, 2018 GNFR
FINAL REFUSAL WRITTEN
May 22, 2018 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 23, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 22, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 22, 2018 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 22, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 22, 2018 REAP
REFUSAL PROCESSED BY IB
Sep 29, 2017 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 14, 2017 RFCS
REFUSAL PROCESSED BY MPU
Sep 14, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 10, 2017 RFCR
NON-FINAL ACTION WRITTEN
Sep 9, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
Sep 5, 2017 MAFR
ASSIGNED TO EXAMINER
Aug 30, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 30, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 24, 2017 REPR